Published • loading... • Updated
Moderna’s Share Price Nearly Doubles on Hopes of Cancer Treatment Breakthrough
Summary by Khbrknews
5 Articles
5 Articles
With its Covid vaccines, the US pharmaceutical company Moderna made a name for itself worldwide. Now it hopes to be able to build on it with a vaccine against skin cancer. A study now inspires new hopes.
·Hamburg, Germany
Read Full Article
With a vaccine against the Coronavirus, Moderna is celebrating a huge success. Now a successful clinical study to combat skin cancer gives the biotech company a huge leap in the course. Several other companies benefit from this.
Shares of the biotechnology company are up 150 percent.
Coverage Details
Total News Sources5
Leaning Left1Leaning Right2Center0Last UpdatedBias Distribution67% Right
Bias Distribution
- 67% of the sources lean Right
67% Right
L 33%
R 67%
Factuality
To view factuality data please Upgrade to Premium
